"/> Novus Biologicals™ Peptide bloquant d’anticorps BC… | B-LABO France

Novus Biologicals™ Peptide bloquant d’anticorps BCMA/TNFRSF17

Réf. : BL-RE-044892Réf. fabricant : 18256628 0.05 mg
201,94 € HT

Highly purified. Generating reliable and reproducible results. Applications: Antibody Competition

Gene ID (Entrez)
608
Espèces
Human
Contenu et stockage
Store at -20 C. Avoid freeze-thaw cycles.
Formule
PBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)
This Peptide is Useful as a Blocking Peptide for NBP1-76774. For Further Blocking Peptide Related Protocol, Click Here .
Marque
Novus Biologicals

A blocking peptide containing 16 amino acids near the carboxy terminus of human BCMA.

Points forts

Source

Synthetic

(Accession #: NP_001183) The BCMA/TNFRSF17 Blocking Peptide has been validated for the following applications: Antibody Competition.

Caractéristiques techniques

MarqueNovus Biologicals
Réf. B-LABOBL-RE-044892
Réf. fabricant18256628
Gene ID (Entrez)608
EspècesHuman
Contenu et stockageStore at -20 C. Avoid freeze-thaw cycles.
FormulePBS pH 7.2 (10 mM NaH2PO4, 10 mM Na2HPO4, 130 mM NaCl) containing 0.1% bovine serum albumin.
À utiliser avec (application)This Peptide is Useful as a Blocking Peptide for NBP1-76774. For Further Blocking Peptide Related Protocol, Click Here .
Alias de gèneB cell maturation antigen, B-cell maturation protein, BCMAtumor necrosis factor receptor superfamily member 17, BCMB-cell maturation factor, CD269, CD269 antigen, tumor necrosis factor receptor superfamily, member 17
Symbole de gène(s)TNFRSF17
Type de produitBCMA/TNFRSF17
Quantité0.05 mg
État réglementaireRUO - research use only
SourceSynthetic
Consigne16 amino acids near the carboxy terminus of human BCMA
Une question, une configuration particulière ?
Contactez-nous pour un devis.